Sample_ID;Diagnosis;Target;Drug;Found_Drug
DFCI_DLBCL_Goe01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DFCI_DLBCL_Goe05;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DFCI_DLBCL_Goe05;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DFCI_DLBCL_Goe05;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DFCI_DLBCL_Goe05;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DFCI_DLBCL_Goe05;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DFCI_DLBCL_Goe16;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL-Ls1065;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL-Ls1098;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL-Ls1098;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL-Ls1098;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL-Ls1098;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL-Ls1395;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL-Ls148;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL-Ls1546;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;AR-42;TRUE
DLBCL-Ls1546;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;BELINOSTAT;TRUE
DLBCL-Ls1546;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;ENTINOSTAT;TRUE
DLBCL-Ls1546;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;REGORAFENIB;TRUE
DLBCL-Ls1546;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;VORINOSTAT;TRUE
DLBCL-Ls1583;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL-Ls1620;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL-Ls1620;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL-Ls1668;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL-Ls1683;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL-Ls1757;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL-Ls1757;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL-Ls1899;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL-Ls1921;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL-Ls2089;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL-Ls2154;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL-Ls2245;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL-Ls2245;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL-Ls2245;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL-Ls2258;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL-Ls2264;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL-Ls2264;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BTK;zanabrutinib;TRUE
DLBCL-Ls2305;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL-Ls2305;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL-Ls2305;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL-Ls2328;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL-Ls2357;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL-Ls2357;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL-Ls2367;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL-Ls2367;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL-Ls2367;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL-Ls2590;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL-Ls2596;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL-Ls297;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL-Ls297;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL-Ls2978;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL-Ls3200;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL-Ls3204;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;ASPARAGINASE;TRUE
DLBCL-Ls3204;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;BORTEZOMIB;TRUE
DLBCL-Ls3204;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;BRONTICTUZUMAB;TRUE
DLBCL-Ls3204;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;DEXAMETHASONE;TRUE
DLBCL-Ls3204;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;HYDROCORTISONE;TRUE
DLBCL-Ls3204;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;MERCAPTOPURINE;TRUE
DLBCL-Ls3204;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;METHOTREXATE;TRUE
DLBCL-Ls3204;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;NIROGACESTAT;TRUE
DLBCL-Ls3204;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;PACLITAXEL;TRUE
DLBCL-Ls3204;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;PREDNISOLONE;TRUE
DLBCL-Ls3204;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;RG-4733;TRUE
DLBCL-Ls3204;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;RIBOCICLIB;TRUE
DLBCL-Ls3204;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;TEMOZOLOMIDE;TRUE
DLBCL-Ls3204;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;WNT-974;TRUE
DLBCL-Ls3245;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL-LS3271;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL-Ls3309;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL-Ls3309;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL-Ls3387;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL-Ls3499;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL-Ls3615;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL-Ls3749;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL-Ls378;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BTK;zanabrutinib;TRUE
DLBCL-Ls3808;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL-Ls3809;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;AR-42;TRUE
DLBCL-Ls3809;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;ASPARAGINASE;TRUE
DLBCL-Ls3809;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;BELINOSTAT;TRUE
DLBCL-Ls3809;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;BORTEZOMIB;TRUE
DLBCL-Ls3809;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;BRONTICTUZUMAB;TRUE
DLBCL-Ls3809;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL-Ls3809;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;DEXAMETHASONE;TRUE
DLBCL-Ls3809;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;ENTINOSTAT;TRUE
DLBCL-Ls3809;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;HYDROCORTISONE;TRUE
DLBCL-Ls3809;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;MERCAPTOPURINE;TRUE
DLBCL-Ls3809;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;METHOTREXATE;TRUE
DLBCL-Ls3809;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;NIROGACESTAT;TRUE
DLBCL-Ls3809;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;PACLITAXEL;TRUE
DLBCL-Ls3809;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;PREDNISOLONE;TRUE
DLBCL-Ls3809;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;REGORAFENIB;TRUE
DLBCL-Ls3809;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;RG-4733;TRUE
DLBCL-Ls3809;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;RIBOCICLIB;TRUE
DLBCL-Ls3809;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;TEMOZOLOMIDE;TRUE
DLBCL-Ls3809;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;VORINOSTAT;TRUE
DLBCL-Ls3809;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;WNT-974;TRUE
DLBCL-Ls3820;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL-Ls3866;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL-Ls3866;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL-LS4054;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL-Ls4085;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL-Ls420;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL-LS4323;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL-LS4394;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL-LS4592;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL-LS4592;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL-LS4592;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL-LS4593;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL-LS4616;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL-LS4616;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL-LS4616;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL-LS4618;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL-LS4618;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL-LS4618;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL-LS4619;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL-Ls762;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL-Ls843;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL-Ls843;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL-Ls951;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CA;APITOLISIB;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;ASPARAGINASE;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;BORTEZOMIB;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;BRONTICTUZUMAB;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CA;BUPARLISIB;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CA;COPANLISIB;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;DEXAMETHASONE;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CA;FIMEPINOSTAT;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;HYDROCORTISONE;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CA;IDELALISIB;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;MERCAPTOPURINE;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;METHOTREXATE;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;NIROGACESTAT;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;PACLITAXEL;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CA;PF-04691502;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CA;PILARALISIB;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;PREDNISOLONE;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;RG-4733;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;RIBOCICLIB;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CA;SONOLISIB;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CA;TASELISIB;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;TEMOZOLOMIDE;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;NOTCH1;WNT-974;TRUE
DLBCL-MAYO_DLBCL_5613;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL-MAYO_DLBCL_7359;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
TCGA-FA-8693-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
TCGA-FA-8693-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
TCGA-FA-8693-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
TCGA-FA-A4BB-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;KMT2D;idelalisib;TRUE
TCGA-FA-A4XK-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
TCGA-FA-A6HN-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
TCGA-FA-A6HO-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
TCGA-FA-A7DS-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;KMT2D;idelalisib;TRUE
TCGA-FA-A7Q1-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
TCGA-FA-A82F-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;KMT2D;idelalisib;TRUE
TCGA-FA-A86F-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;KMT2D;idelalisib;TRUE
TCGA-FF-8041-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;KMT2D;idelalisib;TRUE
TCGA-FF-8042-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;KMT2D;idelalisib;TRUE
TCGA-FF-8043-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;KMT2D;idelalisib;TRUE
TCGA-FF-8046-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
TCGA-FF-8047-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;KMT2D;idelalisib;TRUE
TCGA-FF-8061-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
TCGA-FF-8061-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
TCGA-FF-A7CQ-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
TCGA-FF-A7CR-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
TCGA-FF-A7CR-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
TCGA-FF-A7CR-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;KMT2D;idelalisib;TRUE
TCGA-FF-A7CW-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;KMT2D;idelalisib;TRUE
TCGA-FF-A7CX-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
TCGA-GR-A4D4-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
TCGA-GR-A4D4-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
TCGA-GR-A4D5-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
TCGA-GR-A4D6-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
TCGA-GR-A4D9-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;KMT2D;idelalisib;TRUE
TCGA-GS-A9TQ-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
TCGA-GS-A9TQ-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
TCGA-GS-A9TQ-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
TCGA-GS-A9TQ-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;KMT2D;idelalisib;TRUE
TCGA-GS-A9TQ-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BTK;zanabrutinib;TRUE
TCGA-GS-A9TT-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
TCGA-GS-A9TU-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
TCGA-GS-A9TV-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
TCGA-GS-A9TW-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
TCGA-GS-A9TX-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
TCGA-GS-A9TY-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
TCGA-GS-A9TY-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
TCGA-GS-A9TY-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;KMT2D;idelalisib;TRUE
TCGA-GS-A9TY-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
TCGA-GS-A9TZ-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
TCGA-GS-A9U3-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
TCGA-GS-A9U4-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
TCGA-RQ-A68N-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
TCGA-RQ-AAAT-01;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL-LS1065;Mature B-Cell Neoplasms: Activated B-cell Type;---;---;FALSE
DLBCL-LS1304;Mature B-Cell Neoplasms: Activated B-cell Type;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL-LS1546;Mature B-Cell Neoplasms: Activated B-cell Type;FBXW7;AR-42;TRUE
DLBCL-LS1546;Mature B-Cell Neoplasms: Activated B-cell Type;FBXW7;BELINOSTAT;TRUE
DLBCL-LS1546;Mature B-Cell Neoplasms: Activated B-cell Type;FBXW7;ENTINOSTAT;TRUE
DLBCL-LS1546;Mature B-Cell Neoplasms: Activated B-cell Type;FBXW7;REGORAFENIB;TRUE
DLBCL-LS1546;Mature B-Cell Neoplasms: Activated B-cell Type;FBXW7;VORINOSTAT;TRUE
DLBCL-LS1583;Mature B-Cell Neoplasms: Activated B-cell Type;KMT2D;idelalisib;TRUE
DLBCL-LS1683;Mature B-Cell Neoplasms: Activated B-cell Type;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL-LS1683;Mature B-Cell Neoplasms: Activated B-cell Type;KMT2D;idelalisib;TRUE
DLBCL-LS2089;Mature B-Cell Neoplasms: Activated B-cell Type;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL-LS2154;Mature B-Cell Neoplasms: Activated B-cell Type;---;---;FALSE
DLBCL-LS2208;Mature B-Cell Neoplasms: Activated B-cell Type;---;---;FALSE
DLBCL-LS2258;Mature B-Cell Neoplasms: Activated B-cell Type;---;---;FALSE
DLBCL-LS2590;Mature B-Cell Neoplasms: Activated B-cell Type;KMT2D;idelalisib;TRUE
DLBCL-LS2596;Mature B-Cell Neoplasms: Activated B-cell Type;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL-LS2596;Mature B-Cell Neoplasms: Activated B-cell Type;KMT2D;idelalisib;TRUE
DLBCL-LS2848;Mature B-Cell Neoplasms: Activated B-cell Type;---;---;FALSE
DLBCL-LS2978;Mature B-Cell Neoplasms: Activated B-cell Type;---;---;FALSE
DLBCL-LS3085;Mature B-Cell Neoplasms: Activated B-cell Type;---;---;FALSE
DLBCL-LS3200;Mature B-Cell Neoplasms: Activated B-cell Type;PIK3CA;APITOLISIB;TRUE
DLBCL-LS3200;Mature B-Cell Neoplasms: Activated B-cell Type;PIK3CA;BUPARLISIB;TRUE
DLBCL-LS3200;Mature B-Cell Neoplasms: Activated B-cell Type;PIK3CA;COPANLISIB;TRUE
DLBCL-LS3200;Mature B-Cell Neoplasms: Activated B-cell Type;PIK3CA;FIMEPINOSTAT;TRUE
DLBCL-LS3200;Mature B-Cell Neoplasms: Activated B-cell Type;PIK3CA;IDELALISIB;TRUE
DLBCL-LS3200;Mature B-Cell Neoplasms: Activated B-cell Type;PIK3CA;PF-04691502;TRUE
DLBCL-LS3200;Mature B-Cell Neoplasms: Activated B-cell Type;PIK3CA;PILARALISIB;TRUE
DLBCL-LS3200;Mature B-Cell Neoplasms: Activated B-cell Type;PIK3CA;SONOLISIB;TRUE
DLBCL-LS3200;Mature B-Cell Neoplasms: Activated B-cell Type;PIK3CA;TASELISIB;TRUE
DLBCL-LS3219;Mature B-Cell Neoplasms: Activated B-cell Type;---;---;FALSE
DLBCL-LS3271;Mature B-Cell Neoplasms: Activated B-cell Type;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL-LS3271;Mature B-Cell Neoplasms: Activated B-cell Type;SGK1;ALPELISIB;TRUE
DLBCL-LS3809;Mature B-Cell Neoplasms: Activated B-cell Type;FBXW7;AR-42;TRUE
DLBCL-LS3809;Mature B-Cell Neoplasms: Activated B-cell Type;FBXW7;BELINOSTAT;TRUE
DLBCL-LS3809;Mature B-Cell Neoplasms: Activated B-cell Type;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL-LS3809;Mature B-Cell Neoplasms: Activated B-cell Type;FBXW7;ENTINOSTAT;TRUE
DLBCL-LS3809;Mature B-Cell Neoplasms: Activated B-cell Type;FBXW7;REGORAFENIB;TRUE
DLBCL-LS3809;Mature B-Cell Neoplasms: Activated B-cell Type;FBXW7;VORINOSTAT;TRUE
DLBCL-LS4054;Mature B-Cell Neoplasms: Activated B-cell Type;NOTCH1;ASPARAGINASE;TRUE
DLBCL-LS4054;Mature B-Cell Neoplasms: Activated B-cell Type;NOTCH1;BORTEZOMIB;TRUE
DLBCL-LS4054;Mature B-Cell Neoplasms: Activated B-cell Type;NOTCH1;BRONTICTUZUMAB;TRUE
DLBCL-LS4054;Mature B-Cell Neoplasms: Activated B-cell Type;NOTCH1;DEXAMETHASONE;TRUE
DLBCL-LS4054;Mature B-Cell Neoplasms: Activated B-cell Type;NOTCH1;HYDROCORTISONE;TRUE
DLBCL-LS4054;Mature B-Cell Neoplasms: Activated B-cell Type;NOTCH1;MERCAPTOPURINE;TRUE
DLBCL-LS4054;Mature B-Cell Neoplasms: Activated B-cell Type;NOTCH1;METHOTREXATE;TRUE
DLBCL-LS4054;Mature B-Cell Neoplasms: Activated B-cell Type;NOTCH1;NIROGACESTAT;TRUE
DLBCL-LS4054;Mature B-Cell Neoplasms: Activated B-cell Type;NOTCH1;PACLITAXEL;TRUE
DLBCL-LS4054;Mature B-Cell Neoplasms: Activated B-cell Type;NOTCH1;PREDNISOLONE;TRUE
DLBCL-LS4054;Mature B-Cell Neoplasms: Activated B-cell Type;NOTCH1;RG-4733;TRUE
DLBCL-LS4054;Mature B-Cell Neoplasms: Activated B-cell Type;NOTCH1;RIBOCICLIB;TRUE
DLBCL-LS4054;Mature B-Cell Neoplasms: Activated B-cell Type;NOTCH1;TEMOZOLOMIDE;TRUE
DLBCL-LS4054;Mature B-Cell Neoplasms: Activated B-cell Type;NOTCH1;WNT-974;TRUE
DLBCL-LS4085;Mature B-Cell Neoplasms: Activated B-cell Type;---;---;FALSE
DLBCL-LS4323;Mature B-Cell Neoplasms: Activated B-cell Type;---;---;FALSE
DLBCL-LS88;Mature B-Cell Neoplasms: Activated B-cell Type;NOTCH1;ASPARAGINASE;TRUE
DLBCL-LS88;Mature B-Cell Neoplasms: Activated B-cell Type;NOTCH1;BORTEZOMIB;TRUE
DLBCL-LS88;Mature B-Cell Neoplasms: Activated B-cell Type;NOTCH1;BRONTICTUZUMAB;TRUE
DLBCL-LS88;Mature B-Cell Neoplasms: Activated B-cell Type;NOTCH1;DEXAMETHASONE;TRUE
DLBCL-LS88;Mature B-Cell Neoplasms: Activated B-cell Type;NOTCH1;HYDROCORTISONE;TRUE
DLBCL-LS88;Mature B-Cell Neoplasms: Activated B-cell Type;NOTCH1;MERCAPTOPURINE;TRUE
DLBCL-LS88;Mature B-Cell Neoplasms: Activated B-cell Type;NOTCH1;METHOTREXATE;TRUE
DLBCL-LS88;Mature B-Cell Neoplasms: Activated B-cell Type;NOTCH1;NIROGACESTAT;TRUE
DLBCL-LS88;Mature B-Cell Neoplasms: Activated B-cell Type;NOTCH1;PACLITAXEL;TRUE
DLBCL-LS88;Mature B-Cell Neoplasms: Activated B-cell Type;NOTCH1;PREDNISOLONE;TRUE
DLBCL-LS88;Mature B-Cell Neoplasms: Activated B-cell Type;NOTCH1;RG-4733;TRUE
DLBCL-LS88;Mature B-Cell Neoplasms: Activated B-cell Type;NOTCH1;RIBOCICLIB;TRUE
DLBCL-LS88;Mature B-Cell Neoplasms: Activated B-cell Type;NOTCH1;TEMOZOLOMIDE;TRUE
DLBCL-LS88;Mature B-Cell Neoplasms: Activated B-cell Type;NOTCH1;WNT-974;TRUE
DLBCL-MAYO_DLBCL_5613;Mature B-Cell Neoplasms: Activated B-cell Type;---;---;FALSE
DLBCL-RICOVER_1032;Mature B-Cell Neoplasms: Activated B-cell Type;---;---;FALSE
DLBCL-RICOVER_1060;Mature B-Cell Neoplasms: Activated B-cell Type;---;---;FALSE
DLBCL-RICOVER_1106;Mature B-Cell Neoplasms: Activated B-cell Type;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL-RICOVER_1150;Mature B-Cell Neoplasms: Activated B-cell Type;---;---;FALSE
DLBCL-RICOVER_1169;Mature B-Cell Neoplasms: Activated B-cell Type;---;---;FALSE
DLBCL-RICOVER_1190;Mature B-Cell Neoplasms: Activated B-cell Type;---;---;FALSE
DLBCL-RICOVER_1219;Mature B-Cell Neoplasms: Activated B-cell Type;---;---;FALSE
DLBCL-RICOVER_134;Mature B-Cell Neoplasms: Activated B-cell Type;---;---;FALSE
DLBCL-RICOVER_173;Mature B-Cell Neoplasms: Activated B-cell Type;---;---;FALSE
DLBCL-RICOVER_174;Mature B-Cell Neoplasms: Activated B-cell Type;---;---;FALSE
DLBCL-RICOVER_215;Mature B-Cell Neoplasms: Activated B-cell Type;---;---;FALSE
DLBCL-RICOVER_266;Mature B-Cell Neoplasms: Activated B-cell Type;---;---;FALSE
DLBCL-RICOVER_274;Mature B-Cell Neoplasms: Activated B-cell Type;---;---;FALSE
DLBCL-RICOVER_288;Mature B-Cell Neoplasms: Activated B-cell Type;---;---;FALSE
DLBCL-RICOVER_417;Mature B-Cell Neoplasms: Activated B-cell Type;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL-RICOVER_467;Mature B-Cell Neoplasms: Activated B-cell Type;KMT2D;idelalisib;TRUE
DLBCL-RICOVER_473;Mature B-Cell Neoplasms: Activated B-cell Type;KMT2D;idelalisib;TRUE
DLBCL-RICOVER_506;Mature B-Cell Neoplasms: Activated B-cell Type;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL-RICOVER_597;Mature B-Cell Neoplasms: Activated B-cell Type;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL-RICOVER_704;Mature B-Cell Neoplasms: Activated B-cell Type;---;---;FALSE
DLBCL-RICOVER_712;Mature B-Cell Neoplasms: Activated B-cell Type;---;---;FALSE
DLBCL-RICOVER_720;Mature B-Cell Neoplasms: Activated B-cell Type;CD19;axicabtagene ciloleucel;TRUE
DLBCL-RICOVER_720;Mature B-Cell Neoplasms: Activated B-cell Type;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL-RICOVER_763;Mature B-Cell Neoplasms: Activated B-cell Type;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL-RICOVER_773;Mature B-Cell Neoplasms: Activated B-cell Type;KMT2D;idelalisib;TRUE
DLBCL-RICOVER_910;Mature B-Cell Neoplasms: Activated B-cell Type;---;---;FALSE
DLBCL-RICOVER_977;Mature B-Cell Neoplasms: Activated B-cell Type;---;---;FALSE
DLBCL-RICOVER_99;Mature B-Cell Neoplasms: Activated B-cell Type;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL-DFCI_DLBCL_Goe05;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL-DFCI_DLBCL_Goe05;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL-DFCI_DLBCL_Goe05;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;KMT2D;idelalisib;TRUE
DLBCL-DFCI_DLBCL_Goe05;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL-DFCI_DLBCL_Goe05;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL-DFCI_DLBCL_Goe05;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL-DFCI_DLBCL_Goe08;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL-DFCI_DLBCL_Goe08;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL-DFCI_DLBCL_Goe16;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL-DFCI_DLBCL_Goe16;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL-DFCI_DLBCL_Goe17;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL-LS1098;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL-LS1098;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL-LS1098;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL-LS1098;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;KMT2D;idelalisib;TRUE
DLBCL-LS1395;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL-LS1395;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;KMT2D;idelalisib;TRUE
DLBCL-LS148;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL-LS1668;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL-LS1668;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;KMT2D;idelalisib;TRUE
DLBCL-LS1757;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL-LS1757;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL-LS1757;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;KMT2D;idelalisib;TRUE
DLBCL-LS2264;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL-LS2264;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BTK;zanabrutinib;TRUE
DLBCL-LS2305;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL-LS2305;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL-LS2305;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL-LS2325;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL-LS2357;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL-LS2357;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL-LS2595;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL-LS3615;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL-LS378;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;KMT2D;idelalisib;TRUE
DLBCL-LS378;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BTK;zanabrutinib;TRUE
DLBCL-LS3808;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL-LS4222;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL-LS4394;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;KMT2D;idelalisib;TRUE
DLBCL-LS4593;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL-LS762;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL-LS843;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL-LS843;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;KMT2D;idelalisib;TRUE
DLBCL-LS843;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL-MAYO_DLBCL_7359;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL-RICOVER_102;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL-RICOVER_107;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;KMT2D;idelalisib;TRUE
DLBCL-RICOVER_1199;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL-RICOVER_1235;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL-RICOVER_1235;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;KMT2D;idelalisib;TRUE
DLBCL-RICOVER_1237;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL-RICOVER_1263;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL-RICOVER_1263;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL-RICOVER_1263;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL-RICOVER_151;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL-RICOVER_181;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL-RICOVER_181;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL-RICOVER_181;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL-RICOVER_181;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL-RICOVER_181;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;KMT2D;idelalisib;TRUE
DLBCL-RICOVER_224;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL-RICOVER_314;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL-RICOVER_325;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL-RICOVER_336;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL-RICOVER_336;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL-RICOVER_401;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL-RICOVER_401;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;KMT2D;idelalisib;TRUE
DLBCL-RICOVER_449;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL-RICOVER_449;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;KMT2D;idelalisib;TRUE
DLBCL-RICOVER_543;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL-RICOVER_839;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD19;axicabtagene ciloleucel;TRUE
DLBCL-RICOVER_950;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL-LS146;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;PIK3CA;APITOLISIB;TRUE
DLBCL-LS146;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;PIK3CA;BUPARLISIB;TRUE
DLBCL-LS146;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;PIK3CA;COPANLISIB;TRUE
DLBCL-LS146;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;PIK3CA;FIMEPINOSTAT;TRUE
DLBCL-LS146;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;PIK3CA;IDELALISIB;TRUE
DLBCL-LS146;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;PIK3CA;PF-04691502;TRUE
DLBCL-LS146;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;PIK3CA;PILARALISIB;TRUE
DLBCL-LS146;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;PIK3CA;SONOLISIB;TRUE
DLBCL-LS146;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;PIK3CA;TASELISIB;TRUE
DLBCL-LS155;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;BCL2;ABT-199;TRUE
DLBCL-LS155;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;EZH2;Tazemetostat;TRUE
DLBCL-LS1620;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;BCL2;ABT-199;TRUE
DLBCL-LS1620;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;KMT2D;idelalisib;TRUE
DLBCL-LS1620;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;EZH2;Tazemetostat;TRUE
DLBCL-LS1899;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;---;---;FALSE
DLBCL-LS1921;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;---;---;FALSE
DLBCL-LS2245;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;BCL2;ABT-199;TRUE
DLBCL-LS2245;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL-LS2245;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;SGK1;ALPELISIB;TRUE
DLBCL-LS2245;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;KMT2D;idelalisib;TRUE
DLBCL-LS2328;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;KMT2D;idelalisib;TRUE
DLBCL-LS2367;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL-LS2367;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;SGK1;ALPELISIB;TRUE
DLBCL-LS2367;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL-LS2599;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;BCL2;ABT-199;TRUE
DLBCL-LS297;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;BCL2;ABT-199;TRUE
DLBCL-LS297;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL-LS297;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;EZH2;Tazemetostat;TRUE
DLBCL-LS3204;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;ASPARAGINASE;TRUE
DLBCL-LS3204;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;BORTEZOMIB;TRUE
DLBCL-LS3204;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;BRONTICTUZUMAB;TRUE
DLBCL-LS3204;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;DEXAMETHASONE;TRUE
DLBCL-LS3204;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;HYDROCORTISONE;TRUE
DLBCL-LS3204;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;MERCAPTOPURINE;TRUE
DLBCL-LS3204;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;METHOTREXATE;TRUE
DLBCL-LS3204;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;NIROGACESTAT;TRUE
DLBCL-LS3204;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;PACLITAXEL;TRUE
DLBCL-LS3204;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;PREDNISOLONE;TRUE
DLBCL-LS3204;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;RG-4733;TRUE
DLBCL-LS3204;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;RIBOCICLIB;TRUE
DLBCL-LS3204;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;TEMOZOLOMIDE;TRUE
DLBCL-LS3204;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;WNT-974;TRUE
DLBCL-LS3245;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;BCL2;ABT-199;TRUE
DLBCL-LS3245;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;KMT2D;idelalisib;TRUE
DLBCL-LS3309;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;BCL2;ABT-199;TRUE
DLBCL-LS3309;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;EZH2;Tazemetostat;TRUE
DLBCL-LS3387;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;BCL2;ABT-199;TRUE
DLBCL-LS3387;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;KMT2D;idelalisib;TRUE
DLBCL-LS3499;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;---;---;FALSE
DLBCL-LS3749;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;---;---;FALSE
DLBCL-LS3820;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;BCL2;ABT-199;TRUE
DLBCL-LS3866;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL-LS3866;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;SGK1;ALPELISIB;TRUE
DLBCL-LS4592;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;BCL2;ABT-199;TRUE
DLBCL-LS4592;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL-LS4592;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;SGK1;ALPELISIB;TRUE
DLBCL-LS4592;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;KMT2D;idelalisib;TRUE
DLBCL-LS4592;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;BTK;zanabrutinib;TRUE
DLBCL-LS4616;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;BCL2;ABT-199;TRUE
DLBCL-LS4616;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL-LS4616;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;SGK1;ALPELISIB;TRUE
DLBCL-LS4616;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;KMT2D;idelalisib;TRUE
DLBCL-LS4618;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;BCL2;ABT-199;TRUE
DLBCL-LS4618;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL-LS4618;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;SGK1;ALPELISIB;TRUE
DLBCL-LS4619;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;BCL2;ABT-199;TRUE
DLBCL-LS4619;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;PIK3CD;DUVELISIB;TRUE
DLBCL-LS951;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;---;---;FALSE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;PIK3CA;APITOLISIB;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;FBXW7;AR-42;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;ASPARAGINASE;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;MTOR;AZD-8055;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;FBXW7;BELINOSTAT;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;BORTEZOMIB;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;BRONTICTUZUMAB;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;PIK3CA;BUPARLISIB;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;PIK3CA;COPANLISIB;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;MTOR;DACTOLISIB;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;DEXAMETHASONE;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;PIK3CD;DUVELISIB;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;FBXW7;ENTINOSTAT;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;PIK3CA;FIMEPINOSTAT;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;HYDROCORTISONE;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;KMT2D;idelalisib;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;PIK3CA;IDELALISIB;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;MERCAPTOPURINE;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;METHOTREXATE;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;NIROGACESTAT;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;PACLITAXEL;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;PIK3CA;PF-04691502;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;PIK3CA;PILARALISIB;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;MTOR;PIMECROLIMUS;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;PREDNISOLONE;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;FBXW7;REGORAFENIB;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;RG-4733;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;RIBOCICLIB;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;MTOR;ROTENONE;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;PIK3CA;SONOLISIB;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;PIK3CA;TASELISIB;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;TEMOZOLOMIDE;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;FBXW7;VORINOSTAT;TRUE
DLBCL-MAYO_DLBCL_234;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;WNT-974;TRUE
DLBCL-MAYO_DLBCL_3653;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;---;---;FALSE
DLBCL-RICOVER_1013;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;BCL2;ABT-199;TRUE
DLBCL-RICOVER_1013;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;KMT2D;idelalisib;TRUE
DLBCL-RICOVER_1013;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;JAK1;itacitinib;TRUE
DLBCL-RICOVER_1081;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;KMT2D;idelalisib;TRUE
DLBCL-RICOVER_126;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;BCL2;ABT-199;TRUE
DLBCL-RICOVER_126;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;KMT2D;idelalisib;TRUE
DLBCL-RICOVER_1269;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;BCL2;ABT-199;TRUE
DLBCL-RICOVER_1269;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;KMT2D;idelalisib;TRUE
DLBCL-RICOVER_1269;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;BTK;zanabrutinib;TRUE
DLBCL-RICOVER_148;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL-RICOVER_148;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;SGK1;ALPELISIB;TRUE
DLBCL-RICOVER_197;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;---;---;FALSE
DLBCL-RICOVER_253;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;KMT2D;idelalisib;TRUE
DLBCL-RICOVER_267;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;BCL2;ABT-199;TRUE
DLBCL-RICOVER_267;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL-RICOVER_267;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;KMT2D;idelalisib;TRUE
DLBCL-RICOVER_269;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;BCL2;ABT-199;TRUE
DLBCL-RICOVER_269;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL-RICOVER_269;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;SGK1;ALPELISIB;TRUE
DLBCL-RICOVER_299;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;BCL2;ABT-199;TRUE
DLBCL-RICOVER_299;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL-RICOVER_299;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;KMT2D;idelalisib;TRUE
DLBCL-RICOVER_320;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;---;---;FALSE
DLBCL-RICOVER_338;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL-RICOVER_338;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;SGK1;ALPELISIB;TRUE
DLBCL-RICOVER_338;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;MTOR;AZD-8055;TRUE
DLBCL-RICOVER_338;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;MTOR;DACTOLISIB;TRUE
DLBCL-RICOVER_338;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;MTOR;PIMECROLIMUS;TRUE
DLBCL-RICOVER_338;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;MTOR;ROTENONE;TRUE
DLBCL-RICOVER_338;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL-RICOVER_361;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL-RICOVER_361;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;SGK1;ALPELISIB;TRUE
DLBCL-RICOVER_361;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;PIK3CD;DUVELISIB;TRUE
DLBCL-RICOVER_384;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;BCL2;ABT-199;TRUE
DLBCL-RICOVER_384;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;KMT2D;idelalisib;TRUE
DLBCL-RICOVER_496;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;---;---;FALSE
DLBCL-RICOVER_522;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;BCL2;ABT-199;TRUE
DLBCL-RICOVER_522;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL-RICOVER_522;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;SGK1;ALPELISIB;TRUE
DLBCL-RICOVER_533;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;---;---;FALSE
DLBCL-RICOVER_623;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;MTOR;AZD-8055;TRUE
DLBCL-RICOVER_623;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;MTOR;DACTOLISIB;TRUE
DLBCL-RICOVER_623;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;MTOR;PIMECROLIMUS;TRUE
DLBCL-RICOVER_623;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;MTOR;ROTENONE;TRUE
DLBCL-RICOVER_623;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;EZH2;Tazemetostat;TRUE
DLBCL-RICOVER_623;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL-RICOVER_623;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;BTK;zanabrutinib;TRUE
DLBCL-RICOVER_685;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL-RICOVER_711;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL-RICOVER_711;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_1008;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_1008;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_1016;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_1016;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_1016;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_1016;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_1016;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_1016;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_1016;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_2043;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2044;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2045;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_2046;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2047;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2047;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_2047;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_2048;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2057;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_2057;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_2057;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_2057;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_2057;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_2060;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2072;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2073;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2074;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2075;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2075;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_2076;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2076;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_2076;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_2076;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_2076;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_2076;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_2077;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2078;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2079;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2080;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2081;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2081;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_2083;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2084;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2085;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_2087;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2088;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2089;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_2089;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_2091;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2092;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_2093;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2095;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2097;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_2097;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_2097;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_2097;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_2097;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_2097;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_2097;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_2097;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_2100;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2101;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2102;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_2103;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2106;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2107;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2109;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2110;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2111;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2111;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_2112;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2113;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2114;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2115;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2120;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2121;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2122;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2124;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_2124;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_2125;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2126;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2127;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2128;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2130;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2133;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2134;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2135;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2136;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2137;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_2137;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_2138;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2140;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_2141;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_2141;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_2142;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_2143;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2144;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2145;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2146;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2147;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_2148;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_2149;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2150;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_2151;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2152;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2153;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_2153;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_2153;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_2154;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2155;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2156;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_2157;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_2158;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_2158;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_2158;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_2159;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_2160;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_2161;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_2161;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_2162;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_2163;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2163;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_2163;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_2163;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_2163;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_2163;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_2163;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_2164;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_2165;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2166;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2190;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_2191;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2192;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2193;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2194;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;JAK1;itacitinib;TRUE
DLBCL_DUKE_2195;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2196;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_2196;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_2198;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2199;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2200;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2201;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2203;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;JAK1;itacitinib;TRUE
DLBCL_DUKE_2203;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_2204;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2205;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2206;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2207;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2208;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2209;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2210;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2211;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2211;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_2211;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_2212;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2213;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_2215;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_2216;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_2217;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2217;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_2217;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_2217;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_2219;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2220;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2221;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2222;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2224;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_2225;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2226;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2228;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_2228;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_2229;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2230;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2231;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2232;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2233;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_2234;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_2234;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_2234;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_2235;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2236;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2237;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2238;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2239;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;AR-42;TRUE
DLBCL_DUKE_2239;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;BELINOSTAT;TRUE
DLBCL_DUKE_2239;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;ENTINOSTAT;TRUE
DLBCL_DUKE_2239;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;REGORAFENIB;TRUE
DLBCL_DUKE_2239;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;VORINOSTAT;TRUE
DLBCL_DUKE_2240;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2241;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2242;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2243;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2244;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_2246;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2247;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_2248;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2249;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2250;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2251;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2253;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2254;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BTK;zanabrutinib;TRUE
DLBCL_DUKE_2255;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2256;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2259;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BTK;zanabrutinib;TRUE
DLBCL_DUKE_2260;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_2260;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_2261;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2262;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2262;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_2262;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_2262;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_2262;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_2262;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_2263;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_2269;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2269;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_2270;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2271;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2272;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2273;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_2274;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BTK;zanabrutinib;TRUE
DLBCL_DUKE_2278;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2279;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;JAK1;itacitinib;TRUE
DLBCL_DUKE_2281;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2286;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2290;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_2291;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2293;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2297;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_2297;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_2298;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2298;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_2300;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2302;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_2303;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_2306;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_2307;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2448;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_2449;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_2450;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2450;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_2450;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_2450;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_2450;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_2450;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_2450;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_2450;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_2451;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2453;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2453;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_2455;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2459;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2461;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_2461;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_2461;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_2462;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2463;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2464;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2466;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_2466;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_2467;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BTK;zanabrutinib;TRUE
DLBCL_DUKE_2468;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2469;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2470;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2471;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2472;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2473;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2474;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2475;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2476;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_2477;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2478;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2479;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2480;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;JAK1;itacitinib;TRUE
DLBCL_DUKE_2481;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2482;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2483;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2485;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2487;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_2487;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_2488;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2522;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2523;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2524;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2525;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_2528;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2529;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2530;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2532;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_2533;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_2534;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2538;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2539;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2540;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2541;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_2541;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_2541;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;JAK1;itacitinib;TRUE
DLBCL_DUKE_2541;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BTK;zanabrutinib;TRUE
DLBCL_DUKE_2542;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_2542;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BTK;zanabrutinib;TRUE
DLBCL_DUKE_2543;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2544;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2545;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2547;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2548;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2549;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2550;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2551;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2552;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2553;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2554;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2554;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_2555;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2556;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2559;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2560;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2561;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2561;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_2562;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2565;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2567;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2567;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_2567;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_2570;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2571;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2573;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_2573;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_2573;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_2573;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_2573;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_2575;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2576;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;JAK1;itacitinib;TRUE
DLBCL_DUKE_2577;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2578;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2580;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_2581;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2582;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2585;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2588;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2591;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2593;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2594;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_2596;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2597;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2599;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2600;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_2600;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_2600;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_2602;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2603;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2604;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2605;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_2606;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2606;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_2608;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2608;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_2608;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_2609;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2611;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2612;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2613;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2613;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;JAK1;itacitinib;TRUE
DLBCL_DUKE_2614;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2616;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2617;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2619;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2620;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2621;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2622;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2624;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_2624;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_2626;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2626;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_2626;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_2628;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2629;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2630;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2632;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_2634;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2635;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2636;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_2636;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BTK;zanabrutinib;TRUE
DLBCL_DUKE_2637;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2639;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2640;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_2642;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2643;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2644;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BTK;zanabrutinib;TRUE
DLBCL_DUKE_2646;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2647;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2649;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2650;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2651;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2652;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2654;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_2655;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_2655;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_2656;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2657;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2658;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2659;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2660;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2662;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2662;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_2663;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2664;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2666;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_2666;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_2666;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;AR-42;TRUE
DLBCL_DUKE_2666;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;BELINOSTAT;TRUE
DLBCL_DUKE_2666;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;ENTINOSTAT;TRUE
DLBCL_DUKE_2666;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;REGORAFENIB;TRUE
DLBCL_DUKE_2666;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;VORINOSTAT;TRUE
DLBCL_DUKE_2667;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2669;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;JAK1;itacitinib;TRUE
DLBCL_DUKE_2669;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_2671;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2673;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2675;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2676;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2677;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2677;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_2678;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2680;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BTK;zanabrutinib;TRUE
DLBCL_DUKE_2681;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2684;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2684;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_2685;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2687;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2688;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2689;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2690;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2691;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2692;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2696;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2697;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2698;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2699;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2700;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2704;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2705;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2706;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2707;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_2709;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_2709;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_2709;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_2709;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_2709;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_2709;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_2709;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_2709;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_2713;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_2713;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_2714;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_2714;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_2714;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;JAK1;itacitinib;TRUE
DLBCL_DUKE_2714;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_2714;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_2714;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_2715;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2716;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2718;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2719;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_2720;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2725;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2727;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2728;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2758;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2761;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2762;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_2762;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_2762;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_2762;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_2762;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_2763;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2764;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BTK;zanabrutinib;TRUE
DLBCL_DUKE_2765;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2766;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_2766;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BTK;zanabrutinib;TRUE
DLBCL_DUKE_2767;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_2768;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_2769;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2770;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2771;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2772;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2773;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2775;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;JAK1;itacitinib;TRUE
DLBCL_DUKE_2776;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_2777;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_2778;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2779;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2781;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_2781;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_2781;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_2783;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2784;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_2785;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2786;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_2788;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2789;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_2789;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_2790;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2791;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2792;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_2793;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2794;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_2805;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2806;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_2808;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_2809;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2810;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2812;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_2812;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_2812;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_2812;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_2812;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_2813;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2814;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2815;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_2816;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2818;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2819;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_2820;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_2820;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_2821;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_2823;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2824;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_2826;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2827;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2828;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2829;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2830;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2831;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2832;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2832;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_2832;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_2833;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2834;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_2834;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_2836;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2837;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2838;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_2838;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_2838;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_2838;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_2838;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_2838;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_2839;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2840;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2841;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2843;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2844;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2865;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_2865;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_2865;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_2865;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_2865;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_2867;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2871;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2872;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2873;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_2873;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_2874;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2877;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2878;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_2878;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;JAK1;itacitinib;TRUE
DLBCL_DUKE_2879;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_2879;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_2879;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_2879;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_2879;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_2881;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2882;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2884;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_2884;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_2886;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_2887;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_2888;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2889;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_2891;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;JAK1;itacitinib;TRUE
DLBCL_DUKE_2892;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2894;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_2894;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_2894;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_2894;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_2894;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_2895;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_2895;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_2895;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_2895;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_2895;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_2897;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2898;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2898;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_2899;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_2900;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_2901;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_2901;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_2902;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2903;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2903;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BTK;zanabrutinib;TRUE
DLBCL_DUKE_2904;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_2904;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_2904;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_2904;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_2904;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_2904;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_2904;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_2905;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2905;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_2908;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BTK;zanabrutinib;TRUE
DLBCL_DUKE_2909;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2910;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2912;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2915;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_2915;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;JAK1;itacitinib;TRUE
DLBCL_DUKE_2917;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_2917;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_2917;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_2918;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_2918;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_2919;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2921;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_2922;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2923;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2925;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2928;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2931;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2933;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2934;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_2934;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_2934;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;AR-42;TRUE
DLBCL_DUKE_2934;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;BELINOSTAT;TRUE
DLBCL_DUKE_2934;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_2934;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;ENTINOSTAT;TRUE
DLBCL_DUKE_2934;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;REGORAFENIB;TRUE
DLBCL_DUKE_2934;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;VORINOSTAT;TRUE
DLBCL_DUKE_2935;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2936;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_2936;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_2936;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_2936;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_2936;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_2939;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2939;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;AR-42;TRUE
DLBCL_DUKE_2939;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;BELINOSTAT;TRUE
DLBCL_DUKE_2939;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;ENTINOSTAT;TRUE
DLBCL_DUKE_2939;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;REGORAFENIB;TRUE
DLBCL_DUKE_2939;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;VORINOSTAT;TRUE
DLBCL_DUKE_2944;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2945;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_2946;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BTK;zanabrutinib;TRUE
DLBCL_DUKE_2947;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2948;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_2949;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_2950;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_2951;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_2951;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BTK;zanabrutinib;TRUE
DLBCL_DUKE_2952;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_2953;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2955;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2956;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_2957;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_2957;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_2957;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_2957;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_2957;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_2995;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_2996;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_2998;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_2999;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;AR-42;TRUE
DLBCL_DUKE_2999;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;BELINOSTAT;TRUE
DLBCL_DUKE_2999;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;ENTINOSTAT;TRUE
DLBCL_DUKE_2999;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;REGORAFENIB;TRUE
DLBCL_DUKE_2999;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;VORINOSTAT;TRUE
DLBCL_DUKE_3382;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_3384;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3385;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3386;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_3386;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;JAK1;itacitinib;TRUE
DLBCL_DUKE_3387;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3388;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3389;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3390;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3390;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_3394;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3396;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3396;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_3398;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_3399;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3401;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3401;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3401;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3401;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3401;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3401;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3403;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3404;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3405;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3406;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3407;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3408;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3409;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3411;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BTK;zanabrutinib;TRUE
DLBCL_DUKE_3412;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3412;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3412;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3412;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3412;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3412;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BTK;zanabrutinib;TRUE
DLBCL_DUKE_3413;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3417;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3418;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3419;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3422;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3423;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3423;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_3424;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3429;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_3430;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3430;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3431;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_3432;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3432;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3432;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3432;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3432;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_3432;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3432;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3432;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3433;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3433;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_3434;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;JAK1;itacitinib;TRUE
DLBCL_DUKE_3435;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3438;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3439;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3440;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3441;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3441;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3441;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3441;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3441;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_3441;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3444;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_3446;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3447;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_3447;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BTK;zanabrutinib;TRUE
DLBCL_DUKE_3448;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3449;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3450;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3451;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3451;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_3451;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_3453;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3454;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_3455;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3456;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3457;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3458;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_3459;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_3460;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_3461;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3462;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3462;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3462;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3462;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3462;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3463;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;JAK1;itacitinib;TRUE
DLBCL_DUKE_3464;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_3465;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3467;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3468;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3470;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3471;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3472;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3473;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3474;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3474;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3474;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_3475;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3476;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_3478;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3479;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3480;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3480;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3481;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3481;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3482;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3482;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3482;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;JAK1;itacitinib;TRUE
DLBCL_DUKE_3483;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3483;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3483;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3483;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3483;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3484;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3485;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3485;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;JAK1;itacitinib;TRUE
DLBCL_DUKE_3486;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_3487;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3488;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3488;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_3489;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3490;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3493;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BTK;zanabrutinib;TRUE
DLBCL_DUKE_3495;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3496;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_3496;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_3497;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3498;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3500;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3502;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3503;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3503;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3504;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3504;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BTK;zanabrutinib;TRUE
DLBCL_DUKE_3505;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;AR-42;TRUE
DLBCL_DUKE_3505;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;BELINOSTAT;TRUE
DLBCL_DUKE_3505;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_3505;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;ENTINOSTAT;TRUE
DLBCL_DUKE_3505;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;REGORAFENIB;TRUE
DLBCL_DUKE_3505;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;VORINOSTAT;TRUE
DLBCL_DUKE_3506;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3506;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3506;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3506;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3506;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3507;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3508;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3510;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3511;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_3512;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3513;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3514;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3515;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3517;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3519;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3520;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3521;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3522;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3523;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_3525;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3525;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3525;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3525;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3525;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3525;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3525;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3525;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3527;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3527;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_3528;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3528;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3528;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3528;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_3528;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3528;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3528;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3529;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3531;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;JAK1;itacitinib;TRUE
DLBCL_DUKE_3532;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3535;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3536;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3536;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3537;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3538;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3539;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;JAK1;itacitinib;TRUE
DLBCL_DUKE_3540;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3542;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3545;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3546;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3546;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3546;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3546;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3546;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3547;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3548;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3549;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3549;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3549;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3549;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3549;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3551;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3552;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3555;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3556;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3557;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3558;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3559;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3560;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3561;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3561;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3561;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3562;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3563;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3565;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3566;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;AR-42;TRUE
DLBCL_DUKE_3566;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;BELINOSTAT;TRUE
DLBCL_DUKE_3566;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;ENTINOSTAT;TRUE
DLBCL_DUKE_3566;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;REGORAFENIB;TRUE
DLBCL_DUKE_3566;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;VORINOSTAT;TRUE
DLBCL_DUKE_3580;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_3582;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3582;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3582;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_3582;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3582;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3582;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3584;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3584;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3584;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3584;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3584;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3585;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3586;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3586;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_3587;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3587;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3587;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3587;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3587;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3589;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3590;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3592;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3592;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3593;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3594;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3595;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3596;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3597;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_3600;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3600;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3600;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3600;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3600;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_3600;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3601;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_3602;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_3603;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_3604;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_3606;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3607;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3608;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3609;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3609;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3610;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3611;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3612;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3613;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3613;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3614;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3614;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3615;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3616;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3617;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3618;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3618;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_3618;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BTK;zanabrutinib;TRUE
DLBCL_DUKE_3620;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3622;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3622;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_3623;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3624;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3625;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3625;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3627;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3627;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3627;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3627;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3627;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3627;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3628;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3628;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3629;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3630;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3631;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_3632;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3632;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;JAK1;itacitinib;TRUE
DLBCL_DUKE_3634;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;AR-42;TRUE
DLBCL_DUKE_3634;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;BELINOSTAT;TRUE
DLBCL_DUKE_3634;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;ENTINOSTAT;TRUE
DLBCL_DUKE_3634;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;REGORAFENIB;TRUE
DLBCL_DUKE_3634;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;VORINOSTAT;TRUE
DLBCL_DUKE_3635;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3636;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3636;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3636;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3637;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3638;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3638;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_3639;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3639;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3639;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3640;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3642;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3643;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3643;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3643;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3643;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3643;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3644;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3644;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3645;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3646;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3647;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3648;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3649;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3651;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_3652;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;JAK1;itacitinib;TRUE
DLBCL_DUKE_3653;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3654;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3654;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3655;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3656;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3657;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3659;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3660;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;AR-42;TRUE
DLBCL_DUKE_3660;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;BELINOSTAT;TRUE
DLBCL_DUKE_3660;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;ENTINOSTAT;TRUE
DLBCL_DUKE_3660;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;REGORAFENIB;TRUE
DLBCL_DUKE_3660;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;VORINOSTAT;TRUE
DLBCL_DUKE_3661;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;JAK1;itacitinib;TRUE
DLBCL_DUKE_3662;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_3663;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3664;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3664;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3665;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3666;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3666;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3667;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3668;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3669;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3669;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3671;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_3672;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3673;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3674;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_3675;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;JAK1;itacitinib;TRUE
DLBCL_DUKE_3677;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3679;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3680;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3680;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3680;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3680;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3680;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3681;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3682;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3683;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_3684;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3685;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3686;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3687;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3688;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3688;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3688;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3688;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3688;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3689;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3689;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3689;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3689;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3689;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3691;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3692;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3692;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_3692;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BTK;zanabrutinib;TRUE
DLBCL_DUKE_3693;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3693;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3694;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3694;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3694;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3694;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3694;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3696;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3697;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3698;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_3699;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3700;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3701;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3703;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3704;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3704;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3704;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3704;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3704;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3704;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3706;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3707;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3708;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3708;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;AR-42;TRUE
DLBCL_DUKE_3708;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;BELINOSTAT;TRUE
DLBCL_DUKE_3708;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;ENTINOSTAT;TRUE
DLBCL_DUKE_3708;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;REGORAFENIB;TRUE
DLBCL_DUKE_3708;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;VORINOSTAT;TRUE
DLBCL_DUKE_3709;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BTK;zanabrutinib;TRUE
DLBCL_DUKE_3711;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3712;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3712;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3712;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3712;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3712;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3712;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3712;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3712;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3713;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3715;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3716;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_3717;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_3718;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3719;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3721;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3721;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3721;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3722;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3724;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3724;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3724;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;JAK1;itacitinib;TRUE
DLBCL_DUKE_3725;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3726;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3727;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3728;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3728;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BTK;zanabrutinib;TRUE
DLBCL_DUKE_3729;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_3730;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3731;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3732;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3732;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3732;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3732;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3732;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3733;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3734;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3735;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3736;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3737;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3739;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3740;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3740;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3740;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3740;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3740;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3740;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3740;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3741;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3742;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3743;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3745;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3745;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3745;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;AR-42;TRUE
DLBCL_DUKE_3745;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;BELINOSTAT;TRUE
DLBCL_DUKE_3745;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;ENTINOSTAT;TRUE
DLBCL_DUKE_3745;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;REGORAFENIB;TRUE
DLBCL_DUKE_3745;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;VORINOSTAT;TRUE
DLBCL_DUKE_3746;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3747;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3748;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3749;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_3750;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3751;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3753;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3753;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3753;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3753;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3753;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3754;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3755;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3756;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3757;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3758;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_3759;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_3760;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;AR-42;TRUE
DLBCL_DUKE_3760;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;BELINOSTAT;TRUE
DLBCL_DUKE_3760;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;ENTINOSTAT;TRUE
DLBCL_DUKE_3760;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;REGORAFENIB;TRUE
DLBCL_DUKE_3760;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;VORINOSTAT;TRUE
DLBCL_DUKE_3761;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_3762;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3762;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3762;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3762;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3762;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3763;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3764;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_3765;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3766;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;AR-42;TRUE
DLBCL_DUKE_3766;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;BELINOSTAT;TRUE
DLBCL_DUKE_3766;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;ENTINOSTAT;TRUE
DLBCL_DUKE_3766;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;REGORAFENIB;TRUE
DLBCL_DUKE_3766;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;VORINOSTAT;TRUE
DLBCL_DUKE_3767;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3770;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3770;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3770;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3770;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;JAK1;itacitinib;TRUE
DLBCL_DUKE_3770;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3770;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3770;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3771;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3775;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;JAK1;itacitinib;TRUE
DLBCL_DUKE_3776;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3777;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_3778;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_3779;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3780;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3781;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3782;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3783;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3783;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3784;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;AR-42;TRUE
DLBCL_DUKE_3784;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;BELINOSTAT;TRUE
DLBCL_DUKE_3784;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;ENTINOSTAT;TRUE
DLBCL_DUKE_3784;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;REGORAFENIB;TRUE
DLBCL_DUKE_3784;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;VORINOSTAT;TRUE
DLBCL_DUKE_3785;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3786;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3787;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3810;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3811;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;AR-42;TRUE
DLBCL_DUKE_3811;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;BELINOSTAT;TRUE
DLBCL_DUKE_3811;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;ENTINOSTAT;TRUE
DLBCL_DUKE_3811;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;REGORAFENIB;TRUE
DLBCL_DUKE_3811;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;VORINOSTAT;TRUE
DLBCL_DUKE_3812;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3813;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3814;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3815;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3816;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3817;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;JAK1;itacitinib;TRUE
DLBCL_DUKE_3819;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_3820;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3821;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3822;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3823;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3824;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3825;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3826;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3827;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3828;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3829;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3830;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3830;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3830;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3830;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3830;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3831;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3832;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3832;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3832;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3832;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3832;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3833;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3834;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3835;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3835;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_3836;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3836;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3836;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3836;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3836;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3837;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3837;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3838;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3839;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3840;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3842;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3843;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3845;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3845;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3845;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3845;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3845;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3845;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3845;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3846;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3847;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3848;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3849;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3851;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3852;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3854;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3856;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3857;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3859;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3861;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3865;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3865;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3865;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3865;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3865;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3867;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3871;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3872;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3873;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3875;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3876;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3879;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3879;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3880;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3881;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3882;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3882;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_3883;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3885;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3885;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3885;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3885;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BTK;zanabrutinib;TRUE
DLBCL_DUKE_3886;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3887;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3887;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3887;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3887;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_3888;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3889;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3891;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3892;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3893;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3894;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3895;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3896;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3896;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3896;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3896;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BTK;zanabrutinib;TRUE
DLBCL_DUKE_3898;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3899;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3900;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3900;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_3901;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3901;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_3902;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3902;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3902;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3902;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3902;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3903;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3904;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3905;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_3906;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3907;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;JAK1;itacitinib;TRUE
DLBCL_DUKE_3908;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3909;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BTK;zanabrutinib;TRUE
DLBCL_DUKE_3911;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3911;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_3912;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3913;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3914;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3914;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_3915;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3916;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3916;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3916;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3916;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3916;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3917;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3918;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3918;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3918;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3918;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3918;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3919;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3920;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3921;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3922;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3923;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3923;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3923;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3923;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3923;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3924;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3925;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3925;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3925;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3926;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3927;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3927;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3927;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_3928;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3929;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3929;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3929;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3929;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3929;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3930;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3931;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3931;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3932;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3932;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3932;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3932;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3932;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3932;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3932;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3933;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3935;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3936;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3937;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_3938;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;AR-42;TRUE
DLBCL_DUKE_3938;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3938;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;BELINOSTAT;TRUE
DLBCL_DUKE_3938;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3938;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;ENTINOSTAT;TRUE
DLBCL_DUKE_3938;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3938;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;REGORAFENIB;TRUE
DLBCL_DUKE_3938;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3938;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3938;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;FBXW7;VORINOSTAT;TRUE
DLBCL_DUKE_3939;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3940;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3940;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3941;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3942;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3943;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3944;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3945;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3946;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_3946;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3946;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3948;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_3949;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3950;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3951;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3952;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3953;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3954;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3955;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3956;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3957;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3957;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3957;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_3957;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3957;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3957;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3958;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3959;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3960;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_3961;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3963;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3963;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3963;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3963;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3963;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3964;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3965;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3966;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3967;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3968;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3969;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3971;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3972;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
DLBCL_DUKE_3973;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3974;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
DLBCL_DUKE_3974;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
DLBCL_DUKE_3974;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;PIK3CD;DUVELISIB;TRUE
DLBCL_DUKE_3975;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3976;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3977;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3978;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3979;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3980;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3981;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3982;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3983;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3984;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3985;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3986;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3987;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3988;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3988;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3988;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3988;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3988;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3989;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3990;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;JAK1;itacitinib;TRUE
DLBCL_DUKE_3991;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3992;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3993;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3994;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3995;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;AZD-8055;TRUE
DLBCL_DUKE_3995;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;DACTOLISIB;TRUE
DLBCL_DUKE_3995;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;PIMECROLIMUS;TRUE
DLBCL_DUKE_3995;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;ROTENONE;TRUE
DLBCL_DUKE_3995;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;MTOR;temsirolimus + rituximab + DHAP;TRUE
DLBCL_DUKE_3996;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3997;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_3998;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;JAK1;itacitinib;TRUE
DLBCL_DUKE_3999;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_648;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_658;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_683;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_684;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_689;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;ATM;Cyclophosphamide + Veliparib;TRUE
DLBCL_DUKE_690;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_695;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_702;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_704;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BTK;zanabrutinib;TRUE
DLBCL_DUKE_705;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_707;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;CD79B;Dasanitib-BTKV/PI3KS;TRUE
DLBCL_DUKE_759;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_787;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_790;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_793;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_799;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_800;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_813;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_816;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_823;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_829;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_830;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_831;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DLBCL_DUKE_832;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;BCL2;ABT-199;TRUE
DLBCL_DUKE_832;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;EZH2;Tazemetostat;TRUE
MD903;Mature B-Cell Neoplasms: Activated B-cell Type;CD79B;Dasanitib-BTKV/PI3KS;TRUE
MD903;Mature B-Cell Neoplasms: Activated B-cell Type;KMT2D;idelalisib;TRUE
MD903;Mature B-Cell Neoplasms: Activated B-cell Type;JAK1;itacitinib;TRUE
NU-DUL-1;Mature B-Cell Neoplasms: Activated B-cell Type;KMT2D;idelalisib;TRUE
OCI-Ly3;Mature B-Cell Neoplasms: Activated B-cell Type;---;---;FALSE
RG023;Mature B-Cell Neoplasms: Activated B-cell Type;---;---;FALSE
RG026;Mature B-Cell Neoplasms: Activated B-cell Type;---;---;FALSE
RG027;Mature B-Cell Neoplasms: Activated B-cell Type;---;---;FALSE
RG028;Mature B-Cell Neoplasms: Activated B-cell Type;---;---;FALSE
RG036;Mature B-Cell Neoplasms: Activated B-cell Type;CD79B;Dasanitib-BTKV/PI3KS;TRUE
RG038;Mature B-Cell Neoplasms: Activated B-cell Type;KMT2D;idelalisib;TRUE
RG049;Mature B-Cell Neoplasms: Activated B-cell Type;CD79B;Dasanitib-BTKV/PI3KS;TRUE
RG061;Mature B-Cell Neoplasms: Activated B-cell Type;---;---;FALSE
RG065;Mature B-Cell Neoplasms: Activated B-cell Type;---;---;FALSE
RG074;Mature B-Cell Neoplasms: Activated B-cell Type;CD79B;Dasanitib-BTKV/PI3KS;TRUE
RG081;Mature B-Cell Neoplasms: Activated B-cell Type;---;---;FALSE
RG086;Mature B-Cell Neoplasms: Activated B-cell Type;---;---;FALSE
RG138;Mature B-Cell Neoplasms: Activated B-cell Type;---;---;FALSE
SU-DHL-9;Mature B-Cell Neoplasms: Activated B-cell Type;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
SU-DHL-9;Mature B-Cell Neoplasms: Activated B-cell Type;SGK1;ALPELISIB;TRUE
SU-DHL-9;Mature B-Cell Neoplasms: Activated B-cell Type;MTOR;AZD-8055;TRUE
SU-DHL-9;Mature B-Cell Neoplasms: Activated B-cell Type;ATM;Cyclophosphamide + Veliparib;TRUE
SU-DHL-9;Mature B-Cell Neoplasms: Activated B-cell Type;MTOR;DACTOLISIB;TRUE
SU-DHL-9;Mature B-Cell Neoplasms: Activated B-cell Type;MTOR;PIMECROLIMUS;TRUE
SU-DHL-9;Mature B-Cell Neoplasms: Activated B-cell Type;MTOR;ROTENONE;TRUE
SU-DHL-9;Mature B-Cell Neoplasms: Activated B-cell Type;MTOR;temsirolimus + rituximab + DHAP;TRUE
RG024;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
RG024;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;SGK1;ALPELISIB;TRUE
RG051;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
RG067;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
RG115;Mature B-Cell Neoplasms: Diffuse Large B-Cell Lymphoma, NOS;---;---;FALSE
DB;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;KMT2D;idelalisib;TRUE
DB;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;EZH2;Tazemetostat;TRUE
DOHH-2;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;---;---;FALSE
Karpas422;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;BCL2;ABT-199;TRUE
Karpas422;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;ASPARAGINASE;TRUE
Karpas422;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;BORTEZOMIB;TRUE
Karpas422;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;BRONTICTUZUMAB;TRUE
Karpas422;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;DEXAMETHASONE;TRUE
Karpas422;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;HYDROCORTISONE;TRUE
Karpas422;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;KMT2D;idelalisib;TRUE
Karpas422;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;MERCAPTOPURINE;TRUE
Karpas422;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;METHOTREXATE;TRUE
Karpas422;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;NIROGACESTAT;TRUE
Karpas422;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;PACLITAXEL;TRUE
Karpas422;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;PREDNISOLONE;TRUE
Karpas422;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;RG-4733;TRUE
Karpas422;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;RIBOCICLIB;TRUE
Karpas422;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;EZH2;Tazemetostat;TRUE
Karpas422;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;TEMOZOLOMIDE;TRUE
Karpas422;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;NOTCH1;WNT-974;TRUE
NU-DHL-1;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;BCL2;ABT-199;TRUE
NU-DHL-1;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;KMT2D;idelalisib;TRUE
OCI-Ly1;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;BCL2;ABT-199;TRUE
OCI-Ly1;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
OCI-Ly1;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;SGK1;ALPELISIB;TRUE
OCI-Ly1;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;MTOR;AZD-8055;TRUE
OCI-Ly1;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;MTOR;DACTOLISIB;TRUE
OCI-Ly1;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;KMT2D;idelalisib;TRUE
OCI-Ly1;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;MTOR;PIMECROLIMUS;TRUE
OCI-Ly1;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;MTOR;ROTENONE;TRUE
OCI-Ly1;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;EZH2;Tazemetostat;TRUE
OCI-Ly1;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;MTOR;temsirolimus + rituximab + DHAP;TRUE
OCI-Ly19;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;---;---;FALSE
OCI-Ly7;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;---;---;FALSE
RG003;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;EZH2;Tazemetostat;TRUE
RG008;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;---;---;FALSE
RG013;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;KMT2D;idelalisib;TRUE
RG014;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;EZH2;Tazemetostat;TRUE
RG034;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;---;---;FALSE
RG040;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;BCL2;ABT-199;TRUE
RG043;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;ATM;Cyclophosphamide + Veliparib;TRUE
RG054;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;PIK3CD;DUVELISIB;TRUE
RG055;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;---;---;FALSE
RG064;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;EZH2;Tazemetostat;TRUE
RG068;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;KMT2D;idelalisib;TRUE
RG075;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;EZH2;Tazemetostat;TRUE
RG077;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;BCL2;ABT-199;TRUE
RG082;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;ATM;Cyclophosphamide + Veliparib;TRUE
RG082;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;EZH2;Tazemetostat;TRUE
RG083;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;KMT2D;idelalisib;TRUE
RG083;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;EZH2;Tazemetostat;TRUE
RG111;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
RG111;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;SGK1;ALPELISIB;TRUE
RG116;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
RG116;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;SGK1;ALPELISIB;TRUE
RG130;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;---;---;FALSE
RG132;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;---;---;FALSE
RG135;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;KMT2D;idelalisib;TRUE
RG136;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;---;---;FALSE
RG142;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;SGK1;Akt/protein kinase B signaling inhibitor-2;TRUE
RG142;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;SGK1;ALPELISIB;TRUE
SU-DHL-6;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;BCL2;ABT-199;TRUE
SU-DHL-6;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;KMT2D;idelalisib;TRUE
SU-DHL-6;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;EZH2;Tazemetostat;TRUE
WSU-DLCL2;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;BCL2;ABT-199;TRUE
WSU-DLCL2;Mature B-Cell Neoplasms: Germinal Center B-Cell Type;EZH2;Tazemetostat;TRUE
